Efficacy, pharmacokinetics and safety of subcutaneous versus intravenous CT-P13 in rheumatoid arthritis: a randomized phase I/III trial.

Rene WesthovensPiotr WilandMarek ZawadzkiDelina IvanovaAlfredo Berrocal KasayElias Chalouhi El-KhouriÉva BalázsSergii ShevchukLarisa EliseevaMykola StanislavchukRoman YatsyshynPaweł HrycajJanusz JaworskiVyacheslav ZhdanJakub TreflerPavel ShesternyaSang Joon LeeSung Hyun KimJee Hye SuhSeul Gi LeeNoo Ri HanDae Hyun Yoo

Published in: Rheumatology (Oxford, England) (2021)

ClinicalTrials.gov, https://clinicaltrials.gov/ct2/show/NCT03147248.

Keyphrases

rheumatoid arthritis
image quality
dual energy
computed tomography
contrast enhanced
clinical trial
positron emission tomography
study protocol
magnetic resonance imaging
phase iii
disease activity
high dose
randomized controlled trial
phase ii
interstitial lung disease
systemic lupus erythematosus